Agilent Technologies (NYSE:A) Releases Q1 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its first quarter 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.250-1.280 for the period, compared to the consensus estimate of 1.370. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Stock Performance

Shares of A traded up $0.65 on Monday, reaching $134.49. The company’s stock had a trading volume of 3,261,349 shares, compared to its average volume of 1,720,104. Agilent Technologies has a 12-month low of $124.10 and a 12-month high of $155.35. The stock has a market capitalization of $38.64 billion, a P/E ratio of 27.77, a PEG ratio of 5.89 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The stock’s 50 day simple moving average is $137.90 and its two-hundred day simple moving average is $137.61.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.50%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Citigroup lifted their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Bank of America boosted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company started coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Barclays raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday, October 15th. Finally, UBS Group upped their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $144.36.

Insider Activity

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.